Stephen Hahn, Trump’s FDA nominee, pledges ‘bold action’ on vaping but sidesteps questions on flavor ban
WASHINGTON — President Trump’s nominee to lead the Food and Drug Administration, faced with a barrage of questions on Wednesday about his views on youth vaping, pledged “bold action” to address the crisis but demurred when asked directly by U.S. senators whether he supported a wholesale ban on flavored e-cigarette products.
The comments by Dr. Stephen Hahn, the chief medical executive of MD Anderson Cancer Center, came during his confirmation hearing before the Senate Health Committee. They also came amid reports that the White House has stalled a decision on whether to ban flavored vape products.
